Key result
Confirmatory saline infusion testing identifies primary aldosteronism in 6.6% of screened patients.
Why the study?
Does the obligatory use of confirmatory tests (saline infusion) improve the selection of patients for further diagnosis of primary aldosteronism?
Observational (n=198)
No
Does the obligatory use of confirmatory tests (saline infusion) improve the selection of patients for further diagnosis of primary aldosteronism?
The obligatory use of confirmatory tests like saline infusion in patients screened for primary aldosteronism appears cost-effective by limiting the number of patients requiring further diagnostic workup.
Confirmatory saline infusion may limit further workup after screening; leaves open whether obligatory testing improves selection or cost-effectiveness.
INTRODUCTION: Assessment of the renin-angiotensin-aldosterone system has been recently granted a much greater role in the evaluation of patients with arterial hypertension. There is no single test efficient in selection of patients for second-step etiological investigation. METHODS: Altogether, 198 consecutive patients--119 women (60%) and 79 men (40%)--hospitalized in years 2009-2011 at the Clinical Department of Endocrinology Medical University of Bialystok were diagnosed with primary aldosteronism. In each patient, plasma renin activity and plasma aldosterone concentration (basic and after 2 l NaCl infusion) were evaluated. RESULTS: The percentage of patients with plasma aldosterone concentration ≥ 15 ng/ml was 53 and the percentage of patients with plasma renin activity ≤ 0.1 ng/ml/h was 20. The percentage of patients screened for primary aldosteronism in which the aldosterone:renin ratio exceeded consecutive cut-offs of 20, 30, 40 and 50 were respectively 57, 45, 34 and 29. Among 15 patients in which plasma aldosterone concentration after infusion of 2 l of saline was ≥ 6.5 ng/dl (8.6%), 13 (6.6%) were diagnosed with primary aldosteronism. CONCLUSION: The obligatory use of tests confirming autonomy of aldosterone secretion in patients screened for primary aldosteronism seems cost-effective in limiting the number of patients for further diagnosis.
No takes yet. Share an insight, caveat, or question.
Myśliwiec et al. (2012) conducted an observational in Suspected primary aldosteronism (n=198). Confirmatory testing with NaCl infusion was evaluated on Diagnosis of primary aldosteronism. Confirmatory testing with a 2 L saline infusion identified plasma aldosterone concentration ≥ 6.5 ng/dl in 8.6% of screened patients, leading to a primary aldosteronism diagnosis in 6.6%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: